Corneofungimetry bioassay on Malassezia spp. under ketoconazole and desonide influences

Skin Pharmacology and Physiology

Volumn 18, Issue 2, 2005, Pages 98-102

  Pierard Franchimont C ^a,d   Vroome, V ^b   Cauwenbergh, G ^c   Pierard G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Barrier Therapeutics   (Belgium)

^c Barrier Therapeutics   (United States)

^d CHU SART TILMAN   (Belgium)

Author keywords

Corneofungimetry; Desonide; Fungus; Ketoconazole

Indexed keywords

ANTIFUNGAL AGENT; DESONIDE; KETOCONAZOLE; OLIVE OIL; SEBAZOLE; SEBORIDE; SIBORIDE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG FORMULATION; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; MALASSEZIA; MALASSEZIA FURFUR; MALASSEZIA GLOBOSA; MALASSEZIA RESTRICTA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STRATUM CORNEUM;

ADMINISTRATION, TOPICAL; BIOLOGICAL ASSAY; DESONIDE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; GELS; HUMANS; KETOCONAZOLE; MALASSEZIA; MYCOLOGY; SPECIMEN HANDLING;

EID: 17144368790     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083710     Document Type: Article

References (71)

1. Hay RJ, Graham-Brown RA: Dandruff and seborroeic dermatitis: Causes and management. Clin Exp Dermatol 1997;22:3-6.
2. Piérard GE: Seborrheic dermatitis today, gone tomorrow? The link between the biocenosis and treatment. Dermatology 2003;206:187-188.
3. Gupta AK, Bluhm R: Seborrheic dermatitis. J Eur Acad Dermatol Venereol 2004;18:13-26.
4. Gupta A, Madzia SE, Batra R: Etiology and management of seborrheic dermatitis. Dermatology 2004;208:89-93.
5. Faergemann J: Seborrhoeic dermatitis and Pityrosporum orbiculare: Treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Dactacort), miconazole and hydrocrotisone. Br J Dermatol 1986;38:695-700.
6. Heng MCY, Henderson CL, Barker DC, Haberfelde G: Correlation of Pityrosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique. J Am Acad Dermatol 1990;23:82-86.
7. Piérard-Franchimont C, Arrese JE, Piérard GE: Immunohistochemical aspects of the link between Malassezia ovaliz and seborrhoeic dermatitis. J Eur Acad Dermatol Venereol 1995;4: 14-19.
8. Faergemann J: Management of seborrhoeic dermatitis and pityriasis versicolor. Am J Clin Dermatol 2000;1:75-80.
9. Faergemann J, Bergbrant IM, Dohse M, Scott A, Westgate G: Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: Characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 2001;144:549-556.
10. Guillot J and Guého E: The diversity of Malassezia yeasts confirmed by rRNA sequence and nuclear DNA comparisons. Antonie Van Leeuwenhoek 1995;67:297-314.
11. Guého E, Midgley G and Guillot J: The genus Malassezia with description of four new species. Antonie Van Leeuwenhoek 1996;69:337-355.
12. Guillot J, Guého E, Lesourd M: Identification of Malassezia species: A practical approach. J Mycol Med 1996;6:103-110.
13. Gupta AK, Kohli Y, Li A, Faergemann J, Summerbell, RC: In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br J Dermatol 2000;142:758-765.
14. Piérard GE, Arrese JE, Piérard-Franchimont C: Itraconazole comeofungimetry bioassay on Malassezia species. Mycoses, in press.
15. Nakabayashi A, Sei Y, Guillot J: Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000;38:337-341.
16. Gemmer CM, DeAngelis YM, Theelen B, Boekhout T, Dawson JT Jr: Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology. J Clin Microbiol 2002;40:3350-3357.
17. Van Gerven F, Odds FC: The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: Bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole. Mycoses 1995;38:389-393.
18. Schmidt A, Rühl-Hörster B: In vitro susceptibility of Malassezia furfur against azole compounds. Mycoses 1996;39:309-312.
19. Hammer KA, Carson CF, Riley TV: In vitro activities of ketoconazole, econazole micronazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species. Antimicrob Agents Chemother 2000;44:467-469.
20. Piérard GE, Piérard-Franchimont C, Van Cutsem J, Rurangirwa A, Hoppenbrouwers ML, Schrooten P: Ketoconazole 2% emulsion in the treatment of seborrheic dermatitis. Int J Dermatol 1991;30:806-809.
21. Piérard-Franchimont C, Hermanns JF, Degreef H, Piérard GE: From axioms to new insights into dandruff. Dermatology 2000;200: 93-98.
22. Pari T, Pulimood S, Jacob M, George S, Jeyaseelan L. Thomas K: Randomised double blind controlled trial of 2% ketoconazole cream versus 0.05 % clobetasol 17-butyrate cream in seborrhoeic dermatitis. J Eur Acad Dermatol Venereol 1998;10:89-90.
23. van't Veen AJ, Prevoo RLMA, Velders AJ, Jagtman BA, Van Niel JCG, Stolz E: Betamethasone 17-valerate compared with ketoconazole for topical treatment of seborrhoeic dermatitis of the scalp in adults. Results of a Dutch multicenter study. J Dermatol Treat 1998;9:939-945.
24. Piérard-Franchimont C, Willemaers V, Fraiture AL Piérard GE: Squamometry in seborrheic dermatitis. Int J Dermatol 1999;38:712-715.
25. Tengvall Linder M, Johanson C, Zargari A, Bengtsson A, Van der Ploeg I, Jones I, Harfast B, Scheynius: Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatits and characterization of their cytokine profiles. Clin Exp Allergy 1996;26: 1286-1297.
26. Buentke E, Heftier LC, Wilson JL, Wallin RPA, Lofman C, Chambers BJ, Ljunggren HG, Scheynius A: Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malassezia-influenced cell interaction. J Invest Dermatol 2002;119:850-857.
27. Nikkels AF, Piérard GE: Framing the future of antifungals in atopic dermatitis. Dermatology 2003;206:398-400.
28. Back O, Scheynius A, Johansson SGO: Ketoconazole in atopic dermatitis: Therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res 1995;287:448-451.
29. Letawe C, Piérard-Franchimont C, Piérard GE: Squamometry in rating the efficacy of topical corticosteroids in atopic dermatitis. Eur J Clin Pharmacol 1996;51:253-258.
30. Piérard GE, Piérard-Franchimont C: Skin immune downregulators: From bench to bedside. Curr Top Pharmacol 2003;7:109-116.
31. Piérard-Franchimont C, Piérard GE: A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis. Dermatology 2002;204:344-347.
32. Rurangirwa A, Piérard-Franchimont C, Piérard GE: Culture of fungi on cyanoacryltae skin surface stripings. A quantitative bioassay for evaluating antifungal drugs. Clin Exp Dermatol 1989;14:425-428.
33. Piérard GE, Piérard-Franchimont C, Arrese Estrada J: Comparative study of the activity and lingering effect of topical antifungals. Skin Pharmacol 1993;6:208-214.
34. Arrese JE, Schrooten P, De Doncker P, De Smett H, Cauwenbergh G, Piérard-Franchimont C, Piérard GE: Fungal cultures on cyanoacrylate skin surface strippings as a dose-finding method for topical antifungals. A placebo-controlled study with itraconazole 0.25% and 0.50% cream. J Med Vet Mycol 1995;33: 127-130.
35. Arrese JE, Fogouang L, Piérard-Franchimont C, Piérard GE: Euclidean and fractal computer-assisted corneofungimetry. A comparison of 2% ketoconazole and 1% terbinafine topical formulations. Dermatology 2002;204:222-227.
36. Faergemann J, Aly R, Maibach HI: Growth and filament production of Pityrosporum orbiculare and P. ovale on human stratum corneum in vitro. Acta Dermatol Venereol 1983;63: 388-392.
37. Faergemann J: A new model for growth and filament production of Pityrosporum ovale (orbiculare) on human stratum corneum in vitro. J Invest Dermatol 1989;92:117-119.
38. Naka W, Hanyaku H, Tajima S, Harada T, Nishikawa T: Application of neutral red staining for evaluation of the viability of dermatophytes and Candida in human skin scales. J Med Vet Mycol 1994;32:31-35.
39. Watanabe S, Kano R, Sato H, Nakamura Y, Hasegawa A: The effects of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol 2001;116:769-773.
40. Porro MN, Passi S, Caprilli F, Mercantini R: Induction of hyphae in cultures of pityrosporum by cholesterol and cholesterol esters. J Invest Dermatol 1977;69:531-534.
41. Guillot J and Guého E: The diversity of Malassezia yeasts confirmed by rRNA sequence and nuclear DNA comparisons. Antonie Van Leeuwenhoek 1995;67:297-314.
42. Guého E, Midgley G and Guillot J: The genus Malassezia with description of four new species. Antonie Van Leeuwenhoek 1996;69:337-355.
43. Guillot J. Guého E, Lesourd M: Identification of Malassezia species: A practical approach. J Mycol Med 1996;6:103-110.
44. Gupta AK, Kohli Y, Li A, Faergemann J, Summerbell, RC: In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br J Dermatol 2000;142:758-765.
45. Piérard GE, Arrese JE, Piérard-Franchimont C: Itraconazole corneofungimetry bioassay on Malassezia species. Mycoses, in press.
46. Nakabayashi A, Sei Y, Guillot J: Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000;38:337-341.
47. Gemmer CM, DeAngelis YM, Theelen B, Boekhout T, Dawson JT Jr: Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology. J Clin Microbiol 2002;40:3350-3357.
48. Van Gerven F, Odds FC: The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: Bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole. Mycoses 1995;38:389-393.
49. Schmidt A, Rühl-Hörster B: In vitro susceptibility of Malassezia furfur against azole compounds. Mycoses 1996;39:309-312.
50. Hammer KA, Carson CF, Riley TV: In vitro activities of ketoconazole, econazole micronazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species. Antimicrob Agents Chemother 2000;44:467-469.
51. Piérard GE, Piérard-Franchimont C, Van Cutsem J, Rurangirwa A, Hoppenbrouwers ML, Schrooten P: Ketoconazole 2% emulsion in the treatment of seborrheic dermatitis. Int J Dermatol 1991;30:806-809.
52. Piérard-Franchimont C, Hermanns JF, Degreef H, Piérard GE: From axioms to new insights into dandruff. Dermatology 2000;200: 93-98.
53. Pari T, Pulimood S, Jacob M, George S, Jeyaseelan L. Thomas K: Randomised double blind controlled trial of 2% ketoconazole cream versus 0.05% clobetasol 17-butyrate cream in seborrhoeic dermatitis. J Eur Acad Dermatol Venereol 1998;10:89-90.
54. van't Veen AJ, Prevoo RLMA, Velders AJ, Jagtman BA, Van Niel JCG, Stolz E: Betamethasone 17-valerate compared with ketoconazole for topical treatment of seborrhoeic dermatitis of the scalp in adults. Results of a Dutch multicenter study. J Dermatol Treat 1998;9:939-945.
55. Piérard-Franchimont C, Willemaers V, Fraiture AL Piérard GE: Squamometry in seborrheic dermatitis. Int J Dermatol 1999;38:712-715.
56. Tengvall Linder M, Johanson C, Zargari A, Bengtsson A, Van der Ploeg I, Jones I, Harfast B, Scheynius: Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatits and characterization of their cytokine profiles. Clin Exp Allergy 1996;26: 1286-1297.
57. Buentke E, Heftier LC, Wilson JL, Wallin RPA, Lofman C, Chambers BJ, Ljunggren HG, Scheynius A: Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malassezia-influenced cell interaction. J Invest Dermatol 2002;119:850-857.
58. Nikkels AF, Piérard GE: Framing the future of antifungals in atopic dermatitis. Dermatology 2003;206:398-400.
59. Back O, Scheynius A, Johansson SGO: Ketoconazole in atopic dermatitis: Therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res 1995;287:448-451.
60. Letawe C, Piérard-Franchimont C, Piérard GE: Squamometry in rating the efficacy of topical corticosteroids in atopic dermatitis. Eur J Clin Pharmacol 1996;51:253-258.
61. Piérard GE, Piérard-Franchimont C: Skin immune downregulators: From bench to bedside. Curr Top Pharmacol 2003;7:109-116.
62. Piérard-Franchimont C, Piérard GE: A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis. Dermatology 2002;204:344-347.
63. Rurangirwa A, Piérard-Franchimont C, Piérard GE: Culture of fungi on cyanoacryltae skin surface stripings. A quantitative bioassay for evaluating antifungal drugs. Clin Exp Dermatol 1989;14:425-428.
64. Piérard GE, Piérard-Franchimont C, Arrese Estrada J: Comparative study of the activity and lingering effect of topical antifungals. Skin Pharmacol 1993;6:208-214.
65. Arrese JE, Schrooten P, De Doncker P, De Smett H, Cauwenbergh G, Piérard-Franchimont C, Piérard GE: Fungal cultures on cyanoacrylate skin surface strippings as a dose-finding method for topical antifungals. A placebo-controlled study with itraconazole 0.25% and 0.50% cream. J Med Vet Mycol 1995;33: 127-130.
66. Arrese JE, Fogouang L, Piérard-Franchimont C, Piérard GE: Euclidean and fractal computer-assisted corneofungimetry. A comparison of 2% ketoconazole and 1% terbinafine topical formulations. Dermatology 2002;204:222-227.
67. Faergemann J, Aly R, Maibach HI: Growth and filament production of Pityrosporum orbiculare and P. ovale on human stratum corneum in vitro. Acta Dermatol Venereol 1983;63: 388-392.
68. Faergemann J: A new model for growth and filament production of Pityrosporum ovale (orbiculare) on human stratum corneum in vitro. J Invest Dermatol 1989;92:117-119.
69. Naka W, Hanyaku H, Tajima S, Harada T, Nishikawa T: Application of neutral red staining for evaluation of the viability of dermatophytes and Candida in human skin scales. J Med Vet Mycol 1994;32:31-35.
70. Watanabe S, Kano R, Sato H, Nakamura Y, Hasegawa A: The effects of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol 2001;116:769-773.
71. Porro MN, Passi S, Caprilli F, Mercantini R: Induction of hyphae in cultures of pityrosporum by cholesterol and cholesterol esters. J Invest Dermatol 1977;69:531-534.